Farallon Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,341,424
Closed -$149M 153
2025
Q1
$149M Sell
2,341,424
-523,676
-18% -$33.4M 0.74% 38
2024
Q4
$348M Buy
2,865,100
+285,100
+11% +$34.7M 1.56% 22
2024
Q3
$322M Buy
2,580,000
+285,000
+12% +$35.6M 1.42% 23
2024
Q2
$363M Sell
2,295,000
-158,500
-6% -$25M 1.56% 17
2024
Q1
$318M Buy
2,453,500
+1,243,427
+103% +$161M 1.35% 19
2023
Q4
$117M Sell
1,210,073
-165,127
-12% -$15.9M 0.54% 41
2023
Q3
$167M Buy
1,375,200
+170,000
+14% +$20.6M 0.78% 35
2023
Q2
$138M Buy
1,205,200
+291,900
+32% +$33.4M 0.69% 37
2023
Q1
$126M Sell
913,300
-15,600
-2% -$2.15M 0.69% 41
2022
Q4
$120M Buy
928,900
+173,950
+23% +$22.5M 0.71% 42
2022
Q3
$83.5M Sell
754,950
-430,101
-36% -$47.5M 0.46% 55
2022
Q2
$88.8M Buy
1,185,051
+193,076
+19% +$14.5M 0.48% 55
2022
Q1
$77.5M Buy
991,975
+152,966
+18% +$11.9M 0.37% 55
2021
Q4
$75.6M Buy
839,009
+677,009
+418% +$61M 0.38% 51
2021
Q3
$15M Buy
+162,000
New +$15M 0.07% 114
2021
Q2
Sell
-300,000
Closed -$22.4M 310
2021
Q1
$22.4M Sell
300,000
-300,000
-50% -$22.4M 0.11% 101
2020
Q4
$102M Hold
600,000
0.62% 44
2020
Q3
$84.3M Buy
600,000
+75,000
+14% +$10.5M 0.58% 45
2020
Q2
$84.2M Buy
525,000
+175,000
+50% +$28.1M 0.67% 43
2020
Q1
$34.2M Buy
+350,000
New +$34.2M 0.29% 51
2019
Q4
Hold
0
121
2019
Q3
Sell
-500,000
Closed -$76M 111
2019
Q2
$76M Sell
500,000
-150,000
-23% -$22.8M 0.49% 46
2019
Q1
$77.5M Buy
650,000
+10,000
+2% +$1.19M 0.58% 42
2018
Q4
$69.8M Buy
640,000
+445,000
+228% +$48.6M 0.51% 38
2018
Q3
$31.5M Buy
+195,000
New +$31.5M 0.19% 55